Related references
Note: Only part of the references are listed.Exon 9 skipping of apoptotic caspase-2 pre-mRNA is promoted by SRSF3 through interaction with exon 8
Ha Na Jang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
The HER2 Signaling Network in Breast Cancer-Like a Spider in its Web
A. Dittrich et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2014)
Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells
K. Kurokawa et al.
ONCOGENE (2014)
Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant
Abdullah Alajati et al.
CANCER RESEARCH (2013)
Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5
T. M. Ward et al.
ONCOGENE (2013)
Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence
Y. Tang et al.
ONCOGENE (2013)
SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance
Rong Jia et al.
International Journal of Biological Sciences (2012)
Global Profiling of Alternative Splicing Events and Gene Expression Regulated by hnRNPH/F
Erming Wang et al.
PLOS ONE (2012)
Regulation of Mcl-1 by SRSF1 and SRSF5 in Cancer Cells
Hannah L. Gautrey et al.
PLOS ONE (2012)
Integrative Genome-wide Analysis Reveals Cooperative Regulation of Alternative Splicing by hnRNP Proteins
Stephanie C. Huelga et al.
CELL REPORTS (2012)
Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
Clare V. LeFave et al.
EMBO JOURNAL (2011)
The expression profile of RNA-binding proteins in primary and metastatic colorectal cancer: relationship of heterogeneous nuclear ribonucleoproteins with prognosis
Nicholas R. Hope et al.
HUMAN PATHOLOGY (2011)
Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer
X. He et al.
ONCOGENE (2011)
The Human Splice Variant Δ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse
Cristina Marchini et al.
PLOS ONE (2011)
Molecular mechanisms of eukaryotic pre-mRNA 3' end processing regulation
Stefania Millevoi et al.
NUCLEIC ACIDS RESEARCH (2010)
RNase-assisted RNA chromatography
Gracjan Michlewski et al.
RNA (2010)
A Naturally Occurring HER2 Carboxy-Terminal Fragment Promotes Mammary Tumor Growth and Metastasis
Kim Pedersen et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance
Doyel Mitra et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Splice site strength-dependent activity and genetic buffering by poly-G runs
Xinshu Xiao et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
A physical and functional link between splicing factors promotes pre-mRNA 3' end processing
Stefania Millevoi et al.
NUCLEIC ACIDS RESEARCH (2009)
Multiple and specific mRNA processing targets for the major human hnRNP proteins
Julian P. Venables et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation
Judit Anido et al.
EMBO JOURNAL (2006)
Role of exon-16-deleted HER2 in breast carcinomas
F Castiglioni et al.
ENDOCRINE-RELATED CANCER (2006)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x
D Garneau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heterogeneous nuclear ribonucleoproteins F and H/H′ show differential expression in normal and selected cancer tissues
B Honoré et al.
EXPERIMENTAL CELL RESEARCH (2004)
Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation
A Aigner et al.
ONCOGENE (2001)
Share Paper
